National Center for Advancing Translational Sciences in California
National Center for Advancing Translational Sciences (93.350) awarded $405 million to recipients in California in 107 grants from fiscal 2021 to 2025, 13% of the program's national total. The Regents of the University of California, San Francisco received the most, $60.6 million.
- Awarded in California$405 million
- Awards107
- Share of the program13%
- Rank among states1st of 41
- National total$3.1 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 49 | $75.2 million |
| FY 2022 | 50 | $85.1 million |
| FY 2023 | 40 | $81.2 million |
| FY 2024 | 38 | $81.0 million |
| FY 2025 | 44 | $82.0 million |
Recipients in California
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The Regents of the University of California, San Francisco | Colleges and universities | 11 | $60.6 million |
| University of California, San Diego | Colleges and universities | 14 | $60.2 million |
| The Leland Stanford Junior University | Colleges and universities | 9 | $56.8 million |
| University of California, Los Angeles | Colleges and universities | 7 | $54.5 million |
| University of Southern California | Colleges and universities | 2 | $43.1 million |
| University of California, Davis | Colleges and universities | 5 | $38.4 million |
| Scripps Research Institute | Nonprofits | 6 | $34.8 million |
| University of California Irvine | Colleges and universities | 9 | $24.9 million |
| Cedars-Sinai Medical Center | Nonprofits | 5 | $7.7 million |
| Collaborative Drug Discovery, Inc. | Small businesses | 5 | $5.5 million |
Open opportunities under this program
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
- Limited Competition: NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Programs (R25 - Clinical Trial Not Allowed)
- Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
- Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
- NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
- Clinical and Translational Science Award (UM1 Clinical Trial Optional)
- Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards (CTSA) Program (K12 Clinical Trial Optional)
See all 34 on the program page
Questions people ask
How much National Center for Advancing Translational Sciences money goes to California?
$405 million from fiscal 2021 to 2025, across 107 awards. California ranks 1st of 41 states and territories for this program.
Who receives National Center for Advancing Translational Sciences money in California?
The largest recipient is The Regents of the University of California, San Francisco, with $60.6 million in 11 awards. Next are University of California, San Diego and The Leland Stanford Junior University.
Can organizations in California apply now?
Yes, 34 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
National Center for Advancing Translational Sciences in other states
Other large programs in California
- Grants to States for Medicaid
- Education Stabilization Fund
- Highway Planning and Construction
- Temporary Assistance for Needy Families
- Children's Health Insurance Program
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- National School Lunch Program
- Federal Transit Formula Grants
- Title I Grants to Local Educational Agencies
- Head Start